ArticleJournal of immunology research2022

Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide.

Erkan Topkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.